Merit Financial Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-24,556
Closed -$2.49M 2142
2025
Q4
$2.49M Buy
24,556
+11,500
+88% +$924K 0.02% 558
2025
Q3
$714K Sell
13,056
-1,580
-11% -$78.9K 0.01% 1000
2025
Q2
$778K Buy
14,636
+5,837
+66% +$297K 0.01% 903
2025
Q1
$381K Buy
8,799
+4,609
+110% +$233K 0.01% 1045
2024
Q4
$235K Buy
+4,190
New +$261K ﹤0.01% 1031
2024
Q2
Sell
-5,037
Closed -$313K 923
2024
Q1
$313K Buy
5,037
+1,901
+61% +$120K 0.01% 695
2023
Q4
$232K Buy
+3,136
New +$206K 0.01% 685
2021
Q1
Sell
-1,513
Closed -$200K 237
2020
Q4
$200K Buy
+1,513
New +$183K 0.02% 205
2020
Q3
Sell
-5,802
Closed -$504K 228
2020
Q2
$504K Buy
5,802
+1,041
+22% +$83.2K 0.05% 128
2020
Q1
$276K Buy
+4,761
New +$387K 0.03% 170

Other funds holding EXAS

Merit Financial Group's EXAS Position: Q1 2026 in Review

Merit Financial Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 24,556 shares — an estimated $2.49M sold.

Merit Financial Group first reported a position in EXAS in Q1 2020 and held it in 10 quarters. The position peaked at $2.49M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Merit Financial Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Merit Financial Group sold 24,556 Exact Sciences shares in Q1 2026, an estimated $2.49M.
  • Merit Financial Group first reported a position in Exact Sciences in Q1 2020 and held it in 10 quarters.
  • Merit Financial Group's Exact Sciences position peaked at $2.49M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Merit Financial Group's 13F filing for Q1 2026, filed 15 Apr 2026.